Global Parkinson's Disease (PD) Drugs Market Research Report 2021

Publisher Name :
Date: 29-Jan-2021
No. of pages: 121
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Dopamine Agonist

- Monoamine Oxidase Inhibitors

- Acetylcholinesterase Inhibitors

- Glutamate Inhibitors

Segment by Application

- Hospital

- Family

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Boehringer Ingelheim

- GlaxoSmithKline

- Novartis

- Teva Pharmaceutical Industries

- AbbVie

- Abital Pharma

- Addex Therapeutics

- Biogen

- Eisai

- Eli Lilly

- F. Hoffmann-La Roche

- H. Lundbeck

- Impax Laboratories

- Kyowa Hakko Kirin

- Otsuka Pharmaceutical

- Pfizer

Global Parkinson's Disease (PD) Drugs Market Research Report 2021

Table of Contents
1 Parkinson's Disease (PD) Drugs Market Overview
1.1 Product Overview and Scope of Parkinson's Disease (PD) Drugs
1.2 Parkinson's Disease (PD) Drugs Segment by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Parkinson's Disease (PD) Drugs Segment by Application
1.3.1 Parkinson's Disease (PD) Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Family
1.4 Global Parkinson's Disease (PD) Drugs Market Size Estimates and Forecasts
1.4.1 Global Parkinson's Disease (PD) Drugs Revenue 2016-2027
1.4.2 Global Parkinson's Disease (PD) Drugs Sales 2016-2027
1.4.3 Parkinson's Disease (PD) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Parkinson's Disease (PD) Drugs Market Competition by Manufacturers
2.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
2.5.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Parkinson's Disease (PD) Drugs Players Market Share by Revenue
2.5.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parkinson's Disease (PD) Drugs Retrospective Market Scenario by Region
3.1 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.3.1 North America Parkinson's Disease (PD) Drugs Sales by Country
3.3.2 North America Parkinson's Disease (PD) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.4.1 Europe Parkinson's Disease (PD) Drugs Sales by Country
3.4.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region
3.5.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.6.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country
3.6.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country
3.7.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Parkinson's Disease (PD) Drugs Historic Market Analysis by Type
4.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
4.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Parkinson's Disease (PD) Drugs Price by Type (2016-2021)
5 Global Parkinson's Disease (PD) Drugs Historic Market Analysis by Application
5.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
5.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Parkinson's Disease (PD) Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Boehringer Ingelheim Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GlaxoSmithKline Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novartis Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Corporation Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Pharmaceutical Industries Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AbbVie Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Abital Pharma
6.6.1 Abital Pharma Corporation Information
6.6.2 Abital Pharma Description and Business Overview
6.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Abital Pharma Product Portfolio
6.6.5 Abital Pharma Recent Developments/Updates
6.7 Addex Therapeutics
6.6.1 Addex Therapeutics Corporation Information
6.6.2 Addex Therapeutics Description and Business Overview
6.6.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Addex Therapeutics Product Portfolio
6.7.5 Addex Therapeutics Recent Developments/Updates
6.8 Biogen
6.8.1 Biogen Corporation Information
6.8.2 Biogen Description and Business Overview
6.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biogen Product Portfolio
6.8.5 Biogen Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Eisai Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Corporation Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Eli Lilly Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 F. Hoffmann-La Roche
6.11.1 F. Hoffmann-La Roche Corporation Information
6.11.2 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Description and Business Overview
6.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 F. Hoffmann-La Roche Product Portfolio
6.11.5 F. Hoffmann-La Roche Recent Developments/Updates
6.12 H. Lundbeck
6.12.1 H. Lundbeck Corporation Information
6.12.2 H. Lundbeck Parkinson's Disease (PD) Drugs Description and Business Overview
6.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 H. Lundbeck Product Portfolio
6.12.5 H. Lundbeck Recent Developments/Updates
6.13 Impax Laboratories
6.13.1 Impax Laboratories Corporation Information
6.13.2 Impax Laboratories Parkinson's Disease (PD) Drugs Description and Business Overview
6.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Impax Laboratories Product Portfolio
6.13.5 Impax Laboratories Recent Developments/Updates
6.14 Kyowa Hakko Kirin
6.14.1 Kyowa Hakko Kirin Corporation Information
6.14.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Description and Business Overview
6.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Kyowa Hakko Kirin Product Portfolio
6.14.5 Kyowa Hakko Kirin Recent Developments/Updates
6.15 Otsuka Pharmaceutical
6.15.1 Otsuka Pharmaceutical Corporation Information
6.15.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Description and Business Overview
6.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Otsuka Pharmaceutical Product Portfolio
6.15.5 Otsuka Pharmaceutical Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Parkinson's Disease (PD) Drugs Description and Business Overview
6.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Pfizer Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
7 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
7.1 Parkinson's Disease (PD) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
7.4 Parkinson's Disease (PD) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Parkinson's Disease (PD) Drugs Distributors List
8.3 Parkinson's Disease (PD) Drugs Customers
9 Parkinson's Disease (PD) Drugs Market Dynamics
9.1 Parkinson's Disease (PD) Drugs Industry Trends
9.2 Parkinson's Disease (PD) Drugs Growth Drivers
9.3 Parkinson's Disease (PD) Drugs Market Challenges
9.4 Parkinson's Disease (PD) Drugs Market Restraints
10 Global Market Forecast
10.1 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Type (2022-2027)
10.2 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Application (2022-2027)
10.3 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Parkinson's Disease (PD) Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Parkinson's Disease (PD) Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Parkinson's Disease (PD) Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Parkinson's Disease (PD) Drugs Covered in This Study
Table 5. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Parkinson's Disease (PD) Drugs Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Parkinson's Disease (PD) Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 12. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Parkinson's Disease (PD) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Parkinson's Disease (PD) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2016-2021)
Table 39. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Parkinson's Disease (PD) Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2016-2021)
Table 42. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2016-2021)
Table 44. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Parkinson's Disease (PD) Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2016-2021)
Table 47. Global Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2016-2021)
Table 48. Boehringer Ingelheim Corporation Information
Table 49. Boehringer Ingelheim Description and Business Overview
Table 50. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 52. Boehringer Ingelheim Recent Developments/Updates
Table 53. GlaxoSmithKline Corporation Information
Table 54. GlaxoSmithKline Description and Business Overview
Table 55. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Business Overview
Table 60. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Novartis Parkinson's Disease (PD) Drugs Product
Table 62. Novartis Recent Developments/Updates
Table 63. Teva Pharmaceutical Industries Corporation Information
Table 64. Teva Pharmaceutical Industries Description and Business Overview
Table 65. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product
Table 67. Teva Pharmaceutical Industries Recent Developments/Updates
Table 68. AbbVie Corporation Information
Table 69. AbbVie Description and Business Overview
Table 70. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. AbbVie Parkinson's Disease (PD) Drugs Product
Table 72. AbbVie Recent Developments/Updates
Table 73. Abital Pharma Corporation Information
Table 74. Abital Pharma Description and Business Overview
Table 75. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Abital Pharma Parkinson's Disease (PD) Drugs Product
Table 77. Abital Pharma Recent Developments/Updates
Table 78. Addex Therapeutics Corporation Information
Table 79. Addex Therapeutics Description and Business Overview
Table 80. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Addex Therapeutics Parkinson's Disease (PD) Drugs Product
Table 82. Addex Therapeutics Recent Developments/Updates
Table 83. Biogen Corporation Information
Table 84. Biogen Description and Business Overview
Table 85. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Biogen Parkinson's Disease (PD) Drugs Product
Table 87. Biogen Recent Developments/Updates
Table 88. Eisai Corporation Information
Table 89. Eisai Description and Business Overview
Table 90. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Eisai Parkinson's Disease (PD) Drugs Product
Table 92. Eisai Recent Developments/Updates
Table 93. Eli Lilly Corporation Information
Table 94. Eli Lilly Description and Business Overview
Table 95. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Eli Lilly Parkinson's Disease (PD) Drugs Product
Table 97. Eli Lilly Recent Developments/Updates
Table 98. F. Hoffmann-La Roche Corporation Information
Table 99. F. Hoffmann-La Roche Description and Business Overview
Table 100. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product
Table 102. F. Hoffmann-La Roche Recent Developments/Updates
Table 103. H. Lundbeck Corporation Information
Table 104. H. Lundbeck Description and Business Overview
Table 105. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. H. Lundbeck Parkinson's Disease (PD) Drugs Product
Table 107. H. Lundbeck Recent Developments/Updates
Table 108. Impax Laboratories Corporation Information
Table 109. Impax Laboratories Description and Business Overview
Table 110. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Impax Laboratories Parkinson's Disease (PD) Drugs Product
Table 112. Impax Laboratories Recent Developments/Updates
Table 113. Kyowa Hakko Kirin Corporation Information
Table 114. Kyowa Hakko Kirin Description and Business Overview
Table 115. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product
Table 117. Kyowa Hakko Kirin Recent Developments/Updates
Table 118. Otsuka Pharmaceutical Corporation Information
Table 119. Otsuka Pharmaceutical Description and Business Overview
Table 120. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product
Table 122. Otsuka Pharmaceutical Recent Developments/Updates
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Business Overview
Table 125. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Pfizer Parkinson's Disease (PD) Drugs Product
Table 127. Pfizer Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Parkinson's Disease (PD) Drugs Distributors List
Table 131. Parkinson's Disease (PD) Drugs Customers List
Table 132. Parkinson's Disease (PD) Drugs Market Trends
Table 133. Parkinson's Disease (PD) Drugs Growth Drivers
Table 134. Parkinson's Disease (PD) Drugs Market Restraints
Table 135. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 136. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 140. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 144. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Parkinson's Disease (PD) Drugs
Figure 2. Global Parkinson's Disease (PD) Drugs Market Share by Type in 2020 & 2027
Figure 3. Dopamine Agonist Product Picture
Figure 4. Monoamine Oxidase Inhibitors Product Picture
Figure 5. Acetylcholinesterase Inhibitors Product Picture
Figure 6. Glutamate Inhibitors Product Picture
Figure 7. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Family
Figure 10. Global Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Parkinson's Disease (PD) Drugs Market Size 2016-2027 (US$ Million)
Figure 12. Global Parkinson's Disease (PD) Drugs Sales 2016-2027 (K Pcs)
Figure 13. Global Parkinson's Disease (PD) Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Parkinson's Disease (PD) Drugs Sales Share by Manufacturers in 2020
Figure 15. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Parkinson's Disease (PD) Drugs Players: Market Share by Revenue in 2020
Figure 17. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Figure 19. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2020
Figure 20. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
Figure 21. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region in 2020
Figure 22. U.S. Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Parkinson's Disease (PD) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Parkinson's Disease (PD) Drugs by Type (2016-2021)
Figure 47. Sales Market Share of Parkinson's Disease (PD) Drugs by Application (2016-2021)
Figure 48. Sales Market Share of Parkinson's Disease (PD) Drugs by Application in 2020
Figure 49. Revenue Share of Parkinson's Disease (PD) Drugs by Application (2016-2021)
Figure 50. Revenue Share of Parkinson's Disease (PD) Drugs by Application in 2020
Figure 51. Manufacturing Cost Structure of Parkinson's Disease (PD) Drugs
Figure 52. Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
Figure 53. Parkinson's Disease (PD) Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Parkinsons disease Drug Market Research Report 2021
    Published: 31-Mar-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Carbidopa/Levodopa - Dopamine Receptor Agonists - MAO-Inhibitors Segment by Application......
  • Global Rasagiline Tablet Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 28-Mar-2021        Price: US 2980 Onwards        Pages: 89
    Snapshot The global Rasagiline Tablet market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Rasagiline Tablet by product, region and application, in addition, this report introduces market competition situation among the vendors and company pr......
  • Global Parkinson's Disease Drug Market Analysis 2016-2020 and Forecast 2021-2026
    Published: 25-Feb-2021        Price: US 2980 Onwards        Pages: 108
    Snapshot The global Parkinson's Disease Drug market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Parkinson's Disease Drug by product, region and application, in addition, this report introduces market competition situation among the vendors ......
  • Parkinson's Disease Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 31-Jan-2021        Price: US 3000 Onwards        Pages: 118
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2021
    Published: 29-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Dopamine Agonist - Monoamine Oxidase Inhibitors - Acetylcholinesterase Inhibitors - Glutamate Inhibi......
  • Global Rasagiline Tablet Market Research Report 2021
    Published: 25-Jan-2021        Price: US 2900 Onwards        Pages: 123
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 0.5 mg/Pcs - 1 mg/Pcs Segment by Application - Under 40 Years Old - 40-65 Years Old......
  • Global Parkinson's Disease Therapeutics Professional Survey Report 2021, Forecast to 2026
    Published: 14-Jan-2021        Price: US 3280 Onwards        Pages: 131
    The report forecast global Parkinson's Disease Therapeutics market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively." The report demonstrates detail coverage of P......
  • Global Parkinson's Disease Therapeutics Market Research Report 2021, Forecast to 2026
    Published: 14-Jan-2021        Price: US 2680 Onwards        Pages: 162
    The report forecast global Parkinson's Disease Therapeutics market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively." The report demonstrates detail coverage of P......
  • Global Parkinson's Disease (PD) Drugs Market Outlook 2021
    Published: 24-Dec-2020        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Parkinson's Disease (PD) Drugs market is segmented into - Dopamine Agonist - Monoamine Oxidase Inhibitors......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs